EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardio-Oncology Challenges in Elderly Patients

Ester Topa, Eliana De Rosa, Alessandra Cuomo iD, Francesco Curcio, Marika Rizza, Francesco Elia, Veronica Flocco, Umberto Attanasio iD, Martina Iengo, Francesco Fiore iD, Maria Cristina Luise, Grazia Arpino iD und 18 weitere

Journal of Clinical Medicine · 07.05.2025 · 14 (9) · 3257

DOI: 10.3390/jcm14093257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.05.2025. Verfasst von Ester Topa und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medical Sciences (DISMET), Federico II University, 80131 Naples, Italy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lilly, Pfizer, Roche, and Novartis, Astra Zeneca, Amgen, MSD, Novartis, Sanofi, and BMS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Along with the ageing of the population, cancer and cardiovascular (CV) diseases more frequently coexist, complicating patients’ management. Here, we focus on elderly oncologic patients, describing clinical features and comorbidities, discussing therapeutic management CV risk factors and CV complications risen during our CV follow-up, and exploring the different items of the comprehensive geriatric assessment (CGA) and the correlation between cardiac function by means of standard 2D echocardiography and each of the CGA items.

Methods

A total of 108 consecutive patients (mean age 73.55 ± 5.43 years old; 40.7% females) referred to our cardio-oncology unit were enrolled, and three different groups were identified: Group 1, patients naïve for oncologic treatments (mean age 73.32 ± 5.40; 33% females); Group 2, patients already on antineoplastic protocols (mean age 73.46 ± 5.09; 44.1% females); and Group 3, patients who had already completed cancer treatments (mean age 74.34 ± 6.23; 55% female). The correlation between CGA, performed in a subgroup of 62 patients (57.4%), and echocardiographic parameters was assessed.

Results

Group 2 patients had the highest incidence of CV events (CVEs) (61.8% vs. 14.8% in Group 1, 15% in Group 3; p ≤ 0.001) and withdrawals from oncologic treatments (8.8% vs. none in Group 1; p = 0.035). Group 2 had worse 48-month survival (47.1% vs. 22.2% in Group 1, 20% in Group 3; p = 0.05), which was even more evident when focusing on patients who died during follow-up. When assessing echocardiographic parameters, physical activity showed an inverse correlation with the left ventricular mass index (p = 0.034), while the Frailty index showed a direct correlation with the E/e’ ratio (p = 0.005).

Conclusions

A thorough baseline CV assessment is important in elderly oncologic patients eligible for anticancer treatment. In this population, CGA can be a simple, feasible screening tool that might help identify patients at a greater risk of developing CVEs correlating to several pivotal cardiovascular parameters.

Schlagwörter

Stichwörter der Autor:innen

cardio-oncologycardiovascular baseline evaluationcomprehensive geriatric assessmentechocardiographyelderly

Autor:innen und Institutionen

  • Department of Translational Medical Sciences (DISMET), Federico II University, 80131 Naples, Italy.
  • Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy.
  • Interdepartmental Center of Clinical and Translational Research (CIRCET), Federico II University, 80131 Naples, Italy.
  • Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy.
  • Department of Advanced Biomedical Sciences, Federico II University, 80131 Naples, Italy.
  • Hypertension Research Center "CIRIAPA", Federico II University, 80131 Naples, Italy.

ORCID-Profile: Alessandra Cuomo, Umberto Attanasio, Francesco Fiore, Grazia Arpino, Chiara Carlomagno, Luigi Formisano, Carminia Maria Della Corte, Giulia Martini, Teresa Troiani, Guido Iaccarino, Giuseppe Rengo, Carlo Gabriele Tocchetti

Förderung

  • Lilly, Pfizer, Roche, and Novartis
  • Astra Zeneca
  • Amgen, MSD, Novartis, Sanofi, and BMS
  • VivaLyfe, Univers Formazione, Solaris, Myocardial Solutions, Summeet, Astra Zeneca
  • Italian Ministry of Health

Zitieren

APA

Topa, E., De Rosa, E., Cuomo, A., Curcio, F., Rizza, M., Elia, F., Flocco, V., Attanasio, U., Iengo, M., Fiore, F., Luise, M. C., Arpino, G., Bianco, R., Carlomagno, C., Giuliano, M., Formisano, L., Picardi, M., Della Corte, C. M., Morgillo, F., …, & Tocchetti, C. G. (2025). Cardio-Oncology Challenges in Elderly Patients. Journal of Clinical Medicine, 14(9), 3257. https://doi.org/10.3390/jcm14093257

Vancouver

Topa E, De Rosa E, Cuomo A, Curcio F, Rizza M, Elia F, et al. Cardio-Oncology Challenges in Elderly Patients. Journal of Clinical Medicine. 2025;14(9):3257. doi:10.3390/jcm14093257

BibTeX
@article{Topa2025,
  author = {Topa, Ester and De Rosa, Eliana and Cuomo, Alessandra and Curcio, Francesco and Rizza, Marika and Elia, Francesco and Flocco, Veronica and Attanasio, Umberto and Iengo, Martina and Fiore, Francesco and Luise, Maria Cristina and Arpino, Grazia and Bianco, Roberto and Carlomagno, Chiara and Giuliano, Mario and Formisano, Luigi and Picardi, Marco and Della Corte, Carminia Maria and Morgillo, Floriana and Martini, Giulia and Martinelli, Erika and Napolitano, Stefania and Troiani, Teresa and Esposito, Giovanni and Cittadini, Antonio and Iaccarino, Guido and Rengo, Giuseppe and Abete, Pasquale and Mercurio, Valentina and Tocchetti, Carlo Gabriele},
  title = {Cardio-Oncology Challenges in Elderly Patients},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {3257},
  doi = {10.3390/jcm14093257}
}
Kostenlos starten →